← Eichor
Condition: Prostate Cancer Crpc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Prostate Cancer Crpc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Castrate Resistant Prostate Cancer Enhertu Therapy
Phase 2 · 1 location(s) · Washington D.C. Veterans Affairs Medical Center · NCT06610825Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Pr
Phase 2 · 1 location(s) · Pengyuan Liu · NCT06249750GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
Phase 1 · 1 location(s) · Virginia Commonwealth University · NCT06636123Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detecte
Phase 3 · 4 location(s) · UNICANCER · NCT06276465A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Phase 1/Phase 2 · 24 location(s) · DualityBio Inc. · NCT05785741Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan
Phase 2 · 9 location(s) · Convergent Therapeutics · NCT06549465A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
Phase 1/Phase 2 · 7 location(s) · T.O.A.D. Oncology SA · NCT07258407Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
Phase N/A · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07077239Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Adva
Phase 3 · 102 location(s) · Alliance for Clinical Trials in Oncology · NCT07200830Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · 8 location(s) · Acerand Therapeutics (Hong Kong) Limited · NCT06801236A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC
Phase 1/Phase 2 · 2 location(s) · Radiopharm Theranostics, Ltd · NCT07259213A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Phase 1 · 15 location(s) · IDEAYA Biosciences · NCT07503808A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular
Phase 1 · 83 location(s) · Pfizer · NCT03460977177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/Phase 2 · 4 location(s) · Radiopharm Theranostics, Ltd · NCT07189871Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer
Phase 2 · 3 location(s) · Edwin Posadas, MD · NCT05534646Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 14 location(s) · Acerand Therapeutics (Shanghai) Limited · NCT06380660Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Phase 1 · 27 location(s) · ORIC Pharmaceuticals · NCT05413421A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Phase 1/Phase 2 · 107 location(s) · DualityBio Inc. · NCT05914116The COSMYC Trial (COmbined Suppression of MYC)
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06922318A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2 · 20 location(s) · Kyntra Bio · NCT06842498Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Phase 1 · 1 location(s) · TechnoGenesys, Inc. · NCT06705686Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT06062745AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
Phase 1/Phase 2 · 9 location(s) · Arsenal Biosciences, Inc. · NCT07285694Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
Phase 2 · 1 location(s) · Ebrahim S Delpassand · NCT06972628A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants Wi
Phase 1 · 11 location(s) · IDEAYA Biosciences · NCT07540572Study on Human Bioequivalence of Triprerelin Acetate for Injection
Phase 1 · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06683066The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
Phase 2 · 2 location(s) · University Medical Center Groningen · NCT07038304Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · 1 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07007910
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.